期刊文献+

NDRG1在乳腺浸润性导管癌中的表达及其与侵袭、转移的关系 被引量:9

Expression of N-myc downstream regulated gene 1 in breast invasive duct carcinoma and its relationship with tumor metastasis and invasive potential
下载PDF
导出
摘要 目的研究NDRG1(N-myc downstream regulated gene 1)基因在乳腺浸润性导管癌中的表达,及其与乳腺癌侵袭、转移的关系。方法应用免疫组化法检测26例伴淋巴结转移的乳腺浸润性导管癌和45例无淋巴结转移的乳腺癌中的NDRG1、MMP2、MMP9、TIMP2、E-cad的表达状态。结果乳腺癌伴淋巴结转移的标本中NDRG1的表达率低于无淋巴结转移标本(P<0.01)。NDRG1蛋白的表达与TIMP2的表达正相关(P<0.05);而与MMP2、MMP9和E-cad的表达无关(P>0.05)。结论NDRG1与浸润性导管癌的侵袭和转移能力密切相关,可能是一个候选的肿瘤转移抑制基因,并且可能成为乳腺癌的一个有用的预后指标。 Objective To study the correlation of expression of N-myc downstream regulated gene 1 ( NDRG1 ) with invasion of breast invasive duct carcinoma and lymph node metastasis. Methods A total of 71 specimens including 26 case of primary breast invasive duct carcinoma with lymphnode metastasis, 45 case of non-metastasis breast invasive duct carcinoma were observed. NDRG1 was detected by immunohistochemistry in formalin-fixed and paraffin-embedded sections. At the same time, the correlations of NDRG1 with E-cad, MMP2, MMP9, and TIMP2 were investigated. Results The expression of NDRG1 in breast cancer with metastasis of lymph nodes (9/26) was lower than that of non-metastasis of lymph nodes (32/45) ( P 〈 0.01 ). NDRG1 was positively correlated with TIMP2 ( P 〈 0.05), whereas there was no significant relationship between NDRG1 and E-cad, MMP2, MMP9 in breast cancer. Conclusion NDRG1 protein may play an important role in determine the metastasis and invasion ability of breast invasive duct carcinoma. NDRG1 may be a candidate metastasis suppressor gene for breast cancer and may serve as a useful prognostic marker of breast carcinoma.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2007年第12期1498-1500,共3页 Journal of Shanghai Jiao tong University:Medical Science
关键词 乳腺 浸润性导管癌 转移 NDRG1 MMP TIMP breast invasive duct carcinoma metastasis N-myc downstream-regulated gene 1 MMP TIMP
  • 相关文献

参考文献12

  • 1Van Belzen N, Dinjens WN, Eussen BH, et al. Expressionof differentiation-related genes in colorectal cancer: possible implications for prognosis[ J]. Histol Hitopathol, 1998,13(4) :1233 -1242.
  • 2Bandyopadhyay S, Pai SK, Hirota S, et al. Role of the putative tumor metastasis uppressor gene Drg-1 in brest cancer progression [ J ]. Oncogene, 2004, 23 ( 33 ) :5675 - 5681.
  • 3王震,王芳,魏万里,高倩,王维琦,杨耘,王国英.NDRG1基因在结直肠癌发生发展过程中的表达及其与淋巴结转移的关系[J].中华病理学杂志,2004,33(3):264-265. 被引量:17
  • 4Chang JT, Wang HM, Chang KW, et al. Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHESI[J]. Int J Cancer, 2005, 114(6) :942 -949.
  • 5Bandyopadhyay S, Pai SK, Gross SC, et al. The Drg-1 gene suppresses tumor metasis in prostate cancer[ J]. Cancer Res, 2003,63 (8) :1731 -1736.
  • 6Lachat P, Shaw P, Gebhard S, et al. Expression of NDRG1, a differentiation-related gene, in human tissues [ J ]. Histochem Cell Biol, 2002,118 ( 5 ) :399 - 408.
  • 7Kalaydjieva L, Nikolova A, Turnev I, et al. Hereditary motor and sensory neuropathy-Lom, a novel demyelinating neuropathy associated with deafness in gypsies: clinical, electrophysiological and nerve biopsy findings[ J]. Brain, 1998, 121( Pt 3) : 399 -408.
  • 8Guan RJ, Ford HL, Fu Y, et al. Drg-1 as a differentiation-related, putative metastatic s uppressor gene in human colon cancer [ J ]. Cancer Res, 2000,60( 3 ) :749 - 755.
  • 9Siitonen SM, Kononen JT, Helin HJ, et al. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer[J]. Am J Clin Pathol, 1996,105(4) :394 -402.
  • 10Naylor MS, Stamp GW, Davies BD, et al. Expression and activity of MMPs and regulators in ovarian cancer[ J]. Int J Cancer, 1994, 58(1) :50 -56.

二级参考文献28

  • 1[1]Stetle-Steverson WG, Hewitt R, Corcoran M. Matrix metalloproteinases and tumor invasion:from correlation and causeality to clinic. Sem in Cancer Bio. 1996,7:147-145
  • 2[2]Liotta LA, Stetler-Stevensen WG. tumor Invasion and Metastasis:An Imbalance of Positive and Negative regulation. Cancer Res. 1991 (suppl);51:5054
  • 3[3]Pavloff N, Starus PW, Kishnani NS. A New Inhibitor of Metalloproteinases from Chicken: ChIMP-3. J Biol Chem, 1992,267:17321-17326
  • 4[4]Denhardt DT, Feng B, Edwards DR, et al. Tissue Inhibitor of Metalloproteinases(TIMP, aka EPA): Structure, control of Expression and Biological Functions. Pharamc Them, 1993,59:329
  • 5[5]Greene J. Molecular cloaing and Characterization of Human Tissue Inhibitor of Metalloproteinases 4.J Biol Chem, 1996,271:30375-30380
  • 6[6]Lee E, Vaughan DE, Parikh SH. regulation of Matrix Metalloproteinase and Plasminogen Activator Inhibitor-1 Synthesis by Plasminogen in Cultured Human Vascular Smooth Muscle Cells. Circ Res, 1996,78:44-49
  • 7[7]Khokha R. Antisense RNA-Induce Reluction in Murine TIMP Level Confers Oncogenicity on Swiss 3T3 C ells. Science, 1989,243:949
  • 8[8]Kaya-m.A single ets-related transcription, EIAF, confers invasive phenotype on human cancer cells. Oncogene, 1996 Jan 18,12:221-227
  • 9[9]Khokha R. Zimmer MJ, Graham CH. Suppression of Invasion by Inducible Expression of Tissue Inhibitor of Metalloproteinase-1 (TIMP-1) IN B16-F10 Melanoma cells. J National Cancer Institute, 1992,84:1017
  • 10[10]Declerk YA. Inhibition of Invasion and Metastasis in Cell Transfected with an Inhibitor of Metalloproteinases. Cancer Res, 1992,52:701

共引文献18

同被引文献68

引证文献9

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部